Cellmid’s Evolis Enters China and the US

I have covered Australia based Cellmid and its Évolis line of hair loss products a number of times in the past. However, I always limited my discussion of Cellmid to a small part of my once-a-month “brief items of interest” posts. There are many other companies that are of far more interest to those of us who are looking for a permanent hair loss cure.

Cellmid, Évolis and FGF5

I do not consider the Cellmid’s fibroblast growth factor 5 (FGF5 or FGF-5) based Évolis™ line of natural hair growth products to be any kind of a miracle hair loss treatment. However, it is not out of the question that Évolis products can at least modestly benefit your hair.

There is quite a bit of scientific evidence in regards to the inverse connection between the FGF5 protein and scalp hair growth and length. Perhaps the most well known paper on this subject is one that was co-authored by Dr Claire Higgins and Dr. Angela Christiano in 2014: “FGF5 is a crucial regulator of hair length in humans“.

FGF5 causes hair to stop growing. In the absence of FGF5, people can grow excessively long hair. Cellmid CEO Maria Halasz has quite an interesting story to tell in regards to  the start of her company and product. Some years ago, while on a trip to Japan, she accidentally discovered that certain natural ingredients inhibited FGF5 and promoted hair growth in the process. Hence was born Évolis.

I found the above primarily natural ingredient list on one of Évolis’ product packaging inserts.

Cellmid Enters China and the US in 2018

• In May 2018, it was announced that Cellmid was entering into a distribution deal in China with Beijing Fukangren Bio-PharmTech. The latter will distribute the former’s Évolis anti-aging and hair care products in China.
• In July 2018, Cellmid entered into a sales agreement with US based department stores Neiman Marcus and Bloomingdales. These chains will start selling Évolis hair loss products in September 2018.

Interesting, only one person currently seems to be selling Evolis on Amazon. In contrast, numerous third party vendors are selling Shiseido’s Adenosine based Japanese products.

Note that Maria Halasz purchased $7.5 million worth of Cellmid stock at the end of 2017.

The post Cellmid’s Evolis Enters China and the US appeared first on The End of Hair Loss and Balding.